“This is good news in the fight against cancer. With the launch of this new national resource, anyone can freely access raw genomic and clinical data for 12,000 patients - with more records to follow. Increasing the pool of researchers who...

Better quantification of cancer-immune interactions can reveal which disease mechanisms are in play, and help you discover and validate biomarkers that can lead to more accurate subpopulation stratification methodologies of patients for...

OracleBio, a leading provider of high quality precision histopathology image analysis services to support Pharmaceutical R&D, companion diagnostics development, pathology review and biomarker research, will be exhibiting at the American...

Curious to see how 30,000 practicing oncologists react to this and what the level of interest will be in what the VP has to say.  My general sense over these past few months among oncologists is a fair amount of skepticism to the initiative...

Foundation Medicine will be exhibiting at Booth #24109 during the meeting with over 20 poster presentations and 2 oral presentations at #ASCO16. No doubt that genomic profiling, immunotherapy and liquid biopsy are going to have a huge...

I think that liquid biopsy, that is, using urine or peripheral blood samples will revolutionize cancer care and pathology over time.  Right now testing may be more limited with limited clinical trials but over time I think liquid biopsy will...